Characterizations of sphingosylphosphorylcholine-induced scratching responses in ICR mice using naltrexon, capsaicin, ketotifen and Y-27632.

[1]  H. Salomón,et al.  Sphingosylphosphorylcholine activates dendritic cells, stimulating the production of interleukin‐12 , 2007, Immunology.

[2]  Colin N A Palmer,et al.  Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis , 2006, Nature Genetics.

[3]  K. Honda,et al.  Lysophosphatidic Acid Induces Histamine Release from Mast Cells and Skin Fragments , 2005, Pharmacology.

[4]  Jing Qiao,et al.  GPR4 plays a critical role in endothelial cell function and mediates the effects of sphingosylphosphorylcholine , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[5]  T. Hashimoto,et al.  Itch-Scratch Responses Induced by Lysophosphatidic Acid in Mice , 2004, Pharmacology.

[6]  M. Vanier,et al.  Sphingosylphosphorylcholine in Niemann-Pick Disease Brain: Accumulation in Type A But Not in Type B , 1999, Neurochemical Research.

[7]  A. Fleischer,et al.  Pruritus: a review. , 2003, Acta dermato-venereologica. Supplementum.

[8]  H. Schaller,et al.  Role of the G-Protein-Coupled Receptor GPR12 as High-Affinity Receptor for Sphingosylphosphorylcholine and Its Expression and Function in Brain Development , 2003, The Journal of Neuroscience.

[9]  G. Imokawa,et al.  Sphingosylphosphorylcholine is upregulated in the stratum corneum of patients with atopic dermatitis Published, JLR Papers in Press, October 1, 2002. DOI 10.1194/jlr.M200225-JLR200 , 2003, Journal of Lipid Research.

[10]  Michiyasu Suzuki,et al.  Sphingosylphosphorylcholine Is a Novel Messenger for Rho-Kinase–Mediated Ca2+ Sensitization in the Bovine Cerebral Artery: Unimportant Role for Protein Kinase C , 2002, Circulation research.

[11]  A. Somlyo.  New roads leading to Ca2+ sensitization. , 2002, Circulation research.

[12]  Jeung-Hoon Lee,et al.  Sphingosylphosphorylcholine stimulates cellular fibronectin expression through upregulation of IL-6 in cultured human dermal fibroblasts , 2002, Archives of Dermatological Research.

[13]  O. Witte,et al.  Sphingosylphosphorylcholine and Lysophosphatidylcholine Are Ligands for the G Protein-coupled Receptor GPR4* , 2001, The Journal of Biological Chemistry.

[14]  J. Thiele.  Oxidative Targets in the Stratum corneum , 2001, Skin Pharmacology and Physiology.

[15]  N. Inagaki,et al.  Scratching Behavior in Various Strains of Mice , 2001, Skin Pharmacology and Physiology.

[16]  Yan Xu,et al.  Electrospray ionization mass spectrometry analysis of lysophospholipids in human ascitic fluids: comparison of the lysophospholipid contents in malignant vs nonmalignant ascitic fluids. , 2001, Analytical biochemistry.

[17]  C. Wingard,et al.  Antagonism of Rho-kinase stimulates rat penile erection via a nitric oxide-independent pathway , 2001, Nature Medicine.

[18]  G. Imokawa,et al.  High-expression of sphingomyelin deacylase is an important determinant of ceramide deficiency leading to barrier disruption in atopic dermatitis. , 2000, The Journal of investigative dermatology.

[19]  L. Baudhuin,et al.  Sphingosylphosphorylcholine is a ligand for ovarian cancer G-protein-coupled receptor 1 , 2000, Nature Cell Biology.

[20]  P. Bieńkowski,et al.  Ethanol-reinforced behaviour in the rat: effects of naltrexone. , 1999, European journal of pharmacology.

[21]  G. Imokawa,et al.  Sphingosylphosphorylcholine is a potent inducer of intercellular adhesion molecule-1 expression in human keratinocytes. , 1999, The Journal of investigative dermatology.

[22]  N. Inagaki,et al.  Characterization of antihistamines using biphasic cutaneous reaction in BALB/c mice. , 1998, Life sciences.

[23]  K. Jakobs,et al.  Discrimination between plasma membrane and intracellular target sites of sphingosylphosphorylcholine. , 1998, European journal of pharmacology.

[24]  G. Bray,et al.  Differential expression of insulin receptor tyrosine kinase inhibitor (fetuin) gene in a model of diet-induced obesity. , 1998, Life sciences.

[25]  K. Jakobs,et al.  Molecular diversity of sphingolipid signalling , 1997, FEBS letters.

[26]  T. Nagasawa,et al.  Scratching behavior induced by pruritogenic but not algesiogenic agents in mice. , 1995, European journal of pharmacology.

[27]  Y. Hannun,et al.  Sphingolipid breakdown products: anti-proliferative and tumor-suppressor lipids. , 1993, Biochimica et biophysica acta.

[28]  M Kawashima,et al.  Decreased level of ceramides in stratum corneum of atopic dermatitis: an etiologic factor in atopic dry skin? , 1991, The Journal of investigative dermatology.

[29]  C. Wahlgren.  Itch and atopic dermatitis: clinical and experimental studies. , 1991, Acta dermato-venereologica. Supplementum.

[30]  S. Bevan,et al.  Sensory neuron-specific actions of capsaicin: mechanisms and applications. , 1990, Trends in pharmacological sciences.

[31]  P. Holzer,et al.  Local effector functions of capsaicin-sensitive sensory nerve endings: Involvement of tachykinins, calcitonin gene-related peptide and other neuropeptides , 1988, Neuroscience.

[32]  M. T. Franze de Fernández,et al.  Influence of pH on the conformation of angiotensin II and analog peptides. , 1968, Biochimica et biophysica acta.